Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000545305 | SCV000644672 | benign | Tuberous sclerosis 2 | 2025-02-02 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000574665 | SCV000675527 | likely benign | Hereditary cancer-predisposing syndrome | 2017-09-13 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001569675 | SCV001793801 | likely benign | not provided | 2020-04-01 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000545305 | SCV002041268 | benign | Tuberous sclerosis 2 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000574665 | SCV002534113 | likely benign | Hereditary cancer-predisposing syndrome | 2020-11-16 | criteria provided, single submitter | curation | |
All of Us Research Program, |
RCV003999340 | SCV004817025 | likely benign | Tuberous sclerosis syndrome | 2024-07-10 | criteria provided, single submitter | clinical testing |